SCHEMBL14649441

SCHEMBL14649441

Cn1c2ccccc2c2cc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccc6c(c5)c5cc(-n7c8ccccc8c8ccccc87)ccc5n6C)ccc43)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.53
▸ KDM4E B2RXH2 4/20 0.50
▸ L3MBTL1 Q9Y468 4/20 0.50
▸ MAPT P10636 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ ATM Q13315 1/20 0.46
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ PABPC1 P11940 1/20 0.42
▸ KIF11 P52732 1/20 0.41
▸ NPY5R Q15761 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14649213 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL16848787 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL16791296 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL19718703 0.95 KDM4E (0.55) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL16791294 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL16791293 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL14649338 0.95 KDM4E (0.55) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL16848791 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL22906565 0.95 KDM4E (0.55) GPR3KDM4EL3MBTL1MAPTHPGD
SCHEMBL16791289 0.95 GPR3 (0.48) GPR3KDM4EL3MBTL1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9266865-B2 Material for organic electroluminescent element, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2016-02-23 — — US disclosed
US-9266865-B2 Material for organic electroluminescent element, and organic electroluminescent element using same IDEMITSU KOSAN CO., LTD. (JP) 2016-02-23 — — US disclosed
US-20130020565-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 — — US disclosed
US-20130020565-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020565-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME PRDM9, CD99, L1CAM GPR3 4628/4885KDM4E 407/4885L3MBTL1 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback